NSN 6505-01-693-3211 · NIIN 016933211 · FSC 6505
NO DASHES 6505016933211
In Stock
BALOXAVIR MARBOXIL TABLET
Drugs and Biologicals
Technical characteristics
2 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | BALOXAVIR MARBOXIL TABLET, 40MG, 2S |
| FEAT | SPECIAL FEATURES | IS A POLYMERASE ACIDIC (PA) ENDONUCLEASE INHIBITOR INDICATED FOR THE TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA IN PATIENTS 12 YEARS OF AGE AND OLDER; TAKE A SINGLE DOSE OF XOFLUZA ORALLY WITHIN 48 HOURS OF SYMPTOMS ONSET; AVOID CO-ADMINISTRATION WITH POLYVALENT CATION-CONTAINING LAXATIVES, ANTACIDS, OR ORAL SUPPLEMENTS; ONE ADULT DOSE OF TWO 40 MG TABLETS COME IN BLISTER PACK; STORE XOFLUZA IN ITS BLISTER PACKAGE AT 20 C TO 25 C (68 F TO 77 F); EXCURSIONS PERMITTED TO 15 C TO 30 C (59 F TO 86 F) (SEE USP CONTROLLED ROOM TEMPERATURE). |